|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Deferred offering costs | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | |||||||||||
| Accounts receivable | |||||||||||
| Inventories, net | |||||||||||
| Deferred fulfillment costs | |||||||||||
| Prepaid expenses | |||||||||||
| Advance to related parties | |||||||||||
| Contract assets | |||||||||||
| Other current assets | |||||||||||
| Total current assets | |||||||||||
| Cash and marketable securities held in Trust Account | |||||||||||
| Property and equipment - net | |||||||||||
| Operating lease right of use assets | |||||||||||
| Restricted cash | |||||||||||
| Other non-current assets | |||||||||||
| Total assets | |||||||||||
| LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS' DEFICIT | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable and accrued expenses | |||||||||||
| Warrant liability | |||||||||||
| Promissory note - related party | |||||||||||
| Accounts payable | |||||||||||
| Accrued expenses | |||||||||||
| Accrued offering costs | |||||||||||
| Contract liabilities | |||||||||||
| Other current liabilities | |||||||||||
| Total current liabilities | |||||||||||
| Share-based compensation liability | |||||||||||
| Warrant Liabilities | |||||||||||
| Deferred underwriting fee payable | |||||||||||
| Operating lease liabilities, noncurrent | |||||||||||
| Other non-current liabilities | |||||||||||
| Total liabilities | |||||||||||
| Class A common stock subject to possible redemption 28,750,000 and 25,098,791 shares at redemption value at June 30, 2021 and December 31, 2020, respectively | |||||||||||
| Redeemable convertible preferred stock - $0.0001 par value; 88,353,093 shares authorized and nil shares issued, and outstanding as of December 31, 2021; and 188,353,093 shares authorized, 165,744,062 shares issued and outstanding as of December 31, 2020; aggregate liquidation preference of $239,477 as of December 31, 2020 (Note 9) | |||||||||||
| Stockholders' equity | |||||||||||
| Common stock - Class A shares, $0.0001 par value; 385,000,000 shares authorized, 236,695,241 and 234,844,952 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively; Class C shares, par value $0.0001, 5,750,000 shares issued and outstanding as of March 31, 2023 and December 31, 2022 | |||||||||||
| Class A Common Stock | |||||||||||
| Class B Common Stock | |||||||||||
| Class C Common Stock | |||||||||||
| Total common stock - Class A shares, $0.0001 par value; 385,000,000 shares authorized, 236,695,241 and 234,844,952 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively; Class C shares, par value $0.0001, 5,750,000 shares issued and outstanding as of March 31, 2023 and December 31, 2022 | |||||||||||
| Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 3,833,333 shares issued and outstanding | |||||||||||
| Class C common stock, $0.0001 par value; 15,000,000 shares authorized; 5,750,000 shares issued and outstanding | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated deficit | |||||||||||
| Accumulated other comprehensive (loss) | |||||||||||
| Class A Common Stock | |||||||||||
| Class B Common Stock | |||||||||||
| Class C Common Stock | |||||||||||
| Total stockholders' equity | |||||||||||
| Total liabilities and stockholders equity |
Loading...
